BeOne Medicines
ONC
#647
Rank
ยฃ27.87 B
Marketcap
ยฃ251.87
Share price
-0.03%
Change (1 day)
40.17%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Annual Reports (10-K)

Latest form 10-K annual reports for BeOne Medicines CIK: 0001651308

Thumbnail BeOne Medicines 10-K Annual Report 2024

10-K Annual Report 2024

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2023

10-K Annual Report 2023

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2022

10-K Annual Report 2022

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2021

10-K Annual Report 2021

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2020

10-K Annual Report 2020

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2019

10-K Annual Report 2019

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2018

10-K Annual Report 2018

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2017

10-K Annual Report 2017

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report 2016

10-K Annual Report 2016

Language: English

View Annual Report (10-K)
Thumbnail BeOne Medicines 10-K Annual Report

10-K Annual Report 2016-03-30

Language: English

View Annual Report (10-K)